Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting

Journal of the American College of Cardiology

Volumn 37, Issue 2, 2001, Pages 379-385

  Dao, Quyen ^a   Krishnaswamy, Padma ^a   Kazanegra, Radmila ^a   Harrison, Alex ^a   Amirnovin, Rambod ^a   Lenert, Leslie ^a,b   Clopton, Paul ^a   Alberto, Joel ^a   Hlavin, Patricia ^a   Maisel, Alan S ^b,c  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HEART VENTRICLE OVERLOAD; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY;

AGED; ATRIAL NATRIURETIC FACTOR; CALIFORNIA; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITALS, VETERANS; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS;

EID: 0035133323     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)01156-6     Document Type: Article

References (21)

1. The limited availability of physical signs for estimating hemodynamics in chronic heart failure
2. Recommendations concerning use of echocardiography in hypertension and general population research
3. Prospects for using a blood sample in the diagnosis of heart failure
4. Rapid transcriptional activation and early mRNA turnover of BNP in cardiocyte hypertrophy: Evidence for BNP as an "emergency" cardiac hormone against ventricular overload
5. Natriuretic peptides in detection of heart failure
6. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction
7. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure
8. Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: Implications for clinical practice
9. The natural history of CHF. The Framingham study
10. Consensus recommendations for the management of chronic heart failure
11. Effects of prehospital medications on mortality and length of stay in CHF
12. Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction
13. Natriuretic peptides - Relevance in cardiac disease
14. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction
15. Cloning and sequence analysis of cDNA encoding as a precursor for human brain natriuretic peptide
16. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure
17. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care
18. A rapid bedside test for brain natriuretic peptide accurately predicts cardiac function in patients referred for echocardiography
19. Biochemical detection of left-ventricular systolic dysfunction
20. Plasma brain natriuretic peptide in assessment of acute dyspnea
21. Slopes of a receiver operating curve and likelihood ratios of diagnostic test